Senior Scientist - Neuroinflammation (In Vivo)
About this opportunity
Make your mark for patients
We are looking for a Senior Scientist – Neuroinflammation (In Vivo) who is passionate, collaborative and driven to join us in our Neuroinflammation Research team, based in our UCB Pharma office in Braine-l’Alleud, Belgium.
About the role
You will contribute to the development of innovative therapies by designing and executing in vivo studies in neuroinflammation. Working at the bench, you will generate high-quality data to support target identification, validation and early development programs. This role is ideal for someone who enjoys hands-on laboratory work and wants to make a direct impact on drug discovery.
Who you’ll work with
You will be working in a team that focuses on neuroinflammation and neuroimmune diseases, within a collaborative and multidisciplinary research environment. You will partner with internal experts across biology, pathology and drug discovery, as well as external scientific partners, to advance research programs and deliver meaningful outcomes for patients.
What you’ll do
Design and execute in vivo studies in neurological disease models
Perform dosing, surgery, behavioral testing and tissue collection
Generate and analyze data using imaging and molecular techniques
Apply in vitro and ex vivo approaches to support experiments
Collaborate with internal teams and external research partners
Contribute to ethical processes and animal welfare standards
Interested? For this role we’re looking for the following education, experience and skills
Doctoral degree in neuroscience, immunology, or related field. Postdoctoral experience is preferred. Strong background in the field of neuroinflammation
Experience studying how the peripheral immune system contributes to autoimmune, autoinflammatory and degenerative neurological diseases
Exceptional hands-on experience with in vivo rodent models of neurological disease, FELASA C certification or equivalent is required
Knowledge of neuroinflammation and immune mechanisms in neurological diseases. Experience running experimental autoimmune encephalomyelitis/neuritis (EAE/EAN) or similar is beneficial
Experience in drug discovery within industry or biotechnology preferred
Passionate, strong communication skills with collaborative and proactive mindset
Fluent in English, additional languages are an advantage
Internal applicants should be in their current job for at least 12 months, must meet performance standards and are not on formal corrective/disciplinary process (PIP), warning, final warning, or compliance warning letters within the last 12 months. Please inform your Manager or your Talent Partner before applying to any internal job opportunities.
At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description, this role is hybrid with 40% of your time spent in the office, irrespective of your current contractual agreement. Should your current working arrangements differ, please contact your Talent Partner to discuss, before submitting your application.
UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [email protected] . Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.
Requisition ID: 93528
Recruiter: Petra Demes
Hiring Manager: Silvia Cabre
Talent Partner: Geraldine Beauduin
Job Level: SA I
Please consult HRAnswers for more information on job levels.
Job details
How this role compares
Computed from every other active role in our database, not just this employer's listings.
We don't have enough classified peer data for this role yet, so there's no comparison to show. This happens when a posting's title/category doesn't match any taxonomy rule -- it's excluded rather than compared against the wrong peer group.